Based on the measurements of operating efficiency obtained from Novocure's historical financial statements, Novocure is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, Novocure's Non Current Assets Total are relatively stable compared to the past year. As of 03/18/2025, Non Currrent Assets Other is likely to grow to about 15.3 M, while Short and Long Term Debt Total is likely to drop slightly above 88.5 M. Key indicators impacting Novocure's financial strength include:
The essential information of the day-to-day investment outlook for Novocure includes many different criteria found on its balance sheet. An individual investor should monitor Novocure's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Novocure.
Novocure competes with Globus Medical, Insulet, Inspire Medical, TransMedics, and InMode. NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey. NovoCure operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1167 people.
The reason investors look at the income statement is to determine what Novocure's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Novocure's current stock value. Our valuation model uses many indicators to compare Novocure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novocure competition to find correlations between indicators driving Novocure's intrinsic value. More Info.
Novocure is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Novocure's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Novocure by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Novocure Systematic Risk
Novocure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Novocure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Novocure correlated with the market. If Beta is less than 0 Novocure generally moves in the opposite direction as compared to the market. If Novocure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Novocure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Novocure is generally in the same direction as the market. If Beta > 1 Novocure moves generally in the same direction as, but more than the movement of the benchmark.
Novocure Thematic Clasifications
Novocure is part of several thematic ideas from Medical Equipment to Cancer Fighters. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Novocure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Novocure's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Novocure growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Novocure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Novocure. We use our internally-developed statistical techniques to arrive at the intrinsic value of Novocure based on widely used predictive technical indicators. In general, we focus on analyzing Novocure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Novocure's daily price indicators and compare them against related drivers.
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.